Complete Omics, founded in Baltimore, is driven by a team of expert scientists specializing in molecular diagnostics and Omics-based technologies. Their core mission is to revolutionize global health through advanced diagnostic solutions. The company offers multi-omics diagnostic platforms that integrate various Omics technologies to address critical needs in both basic research and clinical applications, with a particular focus on cancer proteomics and genomics.
Notable figures affiliated with Complete Omics include leading scientists and directors with decades of expertise in molecular biology. The company has collaborated with world leaders in cancer research, establishing robust diagnostic platforms over the past decade. These achievements have positioned Complete Omics as a significant player in the field of molecular diagnostics, contributing to advancements in personalized medicine and improving health outcomes globally.
